Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and azd 1152-hqpa

quinazolines has been researched along with azd 1152-hqpa in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ali, M; Ashford, M; Ashton, S; Boylan, N; Low, S; Nolan, J; Parsons, D; Shin, E; Song, YH; Thrasher, D; Troiano, G; Wang, H; Zale, S1
Ashton, S; Barry, ST; Carnevalli, LS; Curtis, NJ; Ferguson, D; Floc'h, N; Harris, E; Hattersley, M; Hughes, AM; Maratea, K; Pease, EJ; Pilling, JE; Taylor, P; Wen, S; Young, LA1
Fujiwara, Y; Hamada, A; Ohuchi, M; Ryu, S; Shimoi, T; Tamura, K; Yagishita, S; Yonemori, K1

Other Studies

3 other study(ies) available for quinazolines and azd 1152-hqpa

ArticleYear
A novel in situ hydrophobic ion paring (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 05-10, Volume: 229

    Topics: Acetanilides; Animals; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Cholic Acid; Deoxycholic Acid; Dioctyl Sulfosuccinic Acid; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice, Nude; Nanoparticles; Naphthols; Neoplasms; Organophosphates; Polyethylene Glycols; Prodrugs; Quinazolines; Rats, Nude; Rats, Wistar; Tumor Burden

2016
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.
    Molecular cancer therapeutics, 2019, Volume: 18, Issue:5

    Topics: Acetanilides; Animals; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Nanoparticles; Protein Kinase Inhibitors; Quinazolines; Xenograft Model Antitumor Assays

2019
Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging.
    Scientific reports, 2020, 09-23, Volume: 10, Issue:1

    Topics: Acetanilides; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Quinazolines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2020